Cargando…

Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis

BACKGROUND: The aim of this study was to evaluate the clinicopathological factors and prognosis of mucinous carcinoma (MC) with infiltrative invasion, MC with expansile invasion, and high-grade serous carcinoma (HGSC). METHODS: Cases of MC and HGSC between 1984 and 2019 were identified. The clinicop...

Descripción completa

Detalles Bibliográficos
Autores principales: Hada, Taira, Miyamoto, Morikazu, Ishibashi, Hiroki, Matsuura, Hiroko, Kakimoto, Soichiro, Iwahashi, Hideki, Tsuda, Hitoshi, Takano, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772123/
https://www.ncbi.nlm.nih.gov/pubmed/35057833
http://dx.doi.org/10.1186/s13000-022-01195-7
_version_ 1784635776318832640
author Hada, Taira
Miyamoto, Morikazu
Ishibashi, Hiroki
Matsuura, Hiroko
Kakimoto, Soichiro
Iwahashi, Hideki
Tsuda, Hitoshi
Takano, Masashi
author_facet Hada, Taira
Miyamoto, Morikazu
Ishibashi, Hiroki
Matsuura, Hiroko
Kakimoto, Soichiro
Iwahashi, Hideki
Tsuda, Hitoshi
Takano, Masashi
author_sort Hada, Taira
collection PubMed
description BACKGROUND: The aim of this study was to evaluate the clinicopathological factors and prognosis of mucinous carcinoma (MC) with infiltrative invasion, MC with expansile invasion, and high-grade serous carcinoma (HGSC). METHODS: Cases of MC and HGSC between 1984 and 2019 were identified. The clinicopathological factors and prognosis of MC with infiltrative invasion or expansile invasion and HGSC were retrospectively compared. Although our present study included cases in our previous studies, we extended observational period when analysis was performed. Accordingly, our study added increased cases and survival analysis was newly conducted. RESULTS: After pathological review, 27 cases of MC with infiltrative invasion, 25 cases of MC with expansile invasion, and 219 cases of HGSC were included. MC had a better prognosis in terms of progression-free survival (PFS, p < 0.01) and overall survival (OS, p < 0.01) than HGSC for all International Federation of Gynecology and Obstetrics (FIGO) stages; however, multivariate analysis did not show statistical differences in PFS and OS. There were no statistically significant differences in PFS and OS for all FIGO stages between MC with infiltrative invasion and HGSC. However, in cases with FIGO stages II to IV, MC with infiltrative invasion had worse PFS (p < 0.01) and OS (p < 0.01) than HGSC. In univariate analysis, MC with infiltrative invasion was a worse prognostic factor for PFS (hazard ratio [HR] 2.83, p < 0.01) and OS (HR 3.83, p < 0.01) than HGSC. Compared with HGSC, MC with expansile invasion had better PFS (p < 0.01) and OS (p < 0.01). Multivariate analysis demonstrated that MC with expansile invasion was a better prognostic factor for PFS (HR 0.17, p < 0.01) and OS (HR 0.18, p = 0.03) than HGSC. CONCLUSIONS: Compared to the prognosis of HGSC, that of MC was different according to the invasive pattern and FIGO stage. Therefore, future study may be needed to consider this association.
format Online
Article
Text
id pubmed-8772123
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87721232022-01-20 Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis Hada, Taira Miyamoto, Morikazu Ishibashi, Hiroki Matsuura, Hiroko Kakimoto, Soichiro Iwahashi, Hideki Tsuda, Hitoshi Takano, Masashi Diagn Pathol Research BACKGROUND: The aim of this study was to evaluate the clinicopathological factors and prognosis of mucinous carcinoma (MC) with infiltrative invasion, MC with expansile invasion, and high-grade serous carcinoma (HGSC). METHODS: Cases of MC and HGSC between 1984 and 2019 were identified. The clinicopathological factors and prognosis of MC with infiltrative invasion or expansile invasion and HGSC were retrospectively compared. Although our present study included cases in our previous studies, we extended observational period when analysis was performed. Accordingly, our study added increased cases and survival analysis was newly conducted. RESULTS: After pathological review, 27 cases of MC with infiltrative invasion, 25 cases of MC with expansile invasion, and 219 cases of HGSC were included. MC had a better prognosis in terms of progression-free survival (PFS, p < 0.01) and overall survival (OS, p < 0.01) than HGSC for all International Federation of Gynecology and Obstetrics (FIGO) stages; however, multivariate analysis did not show statistical differences in PFS and OS. There were no statistically significant differences in PFS and OS for all FIGO stages between MC with infiltrative invasion and HGSC. However, in cases with FIGO stages II to IV, MC with infiltrative invasion had worse PFS (p < 0.01) and OS (p < 0.01) than HGSC. In univariate analysis, MC with infiltrative invasion was a worse prognostic factor for PFS (hazard ratio [HR] 2.83, p < 0.01) and OS (HR 3.83, p < 0.01) than HGSC. Compared with HGSC, MC with expansile invasion had better PFS (p < 0.01) and OS (p < 0.01). Multivariate analysis demonstrated that MC with expansile invasion was a better prognostic factor for PFS (HR 0.17, p < 0.01) and OS (HR 0.18, p = 0.03) than HGSC. CONCLUSIONS: Compared to the prognosis of HGSC, that of MC was different according to the invasive pattern and FIGO stage. Therefore, future study may be needed to consider this association. BioMed Central 2022-01-20 /pmc/articles/PMC8772123/ /pubmed/35057833 http://dx.doi.org/10.1186/s13000-022-01195-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hada, Taira
Miyamoto, Morikazu
Ishibashi, Hiroki
Matsuura, Hiroko
Kakimoto, Soichiro
Iwahashi, Hideki
Tsuda, Hitoshi
Takano, Masashi
Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis
title Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis
title_full Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis
title_fullStr Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis
title_full_unstemmed Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis
title_short Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis
title_sort comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772123/
https://www.ncbi.nlm.nih.gov/pubmed/35057833
http://dx.doi.org/10.1186/s13000-022-01195-7
work_keys_str_mv AT hadataira comparisonofclinicalbehaviorbetweenmucinousovariancarcinomawithinfiltrativeandexpansileinvasionandhighgradeserousovariancarcinomaaretrospectiveanalysis
AT miyamotomorikazu comparisonofclinicalbehaviorbetweenmucinousovariancarcinomawithinfiltrativeandexpansileinvasionandhighgradeserousovariancarcinomaaretrospectiveanalysis
AT ishibashihiroki comparisonofclinicalbehaviorbetweenmucinousovariancarcinomawithinfiltrativeandexpansileinvasionandhighgradeserousovariancarcinomaaretrospectiveanalysis
AT matsuurahiroko comparisonofclinicalbehaviorbetweenmucinousovariancarcinomawithinfiltrativeandexpansileinvasionandhighgradeserousovariancarcinomaaretrospectiveanalysis
AT kakimotosoichiro comparisonofclinicalbehaviorbetweenmucinousovariancarcinomawithinfiltrativeandexpansileinvasionandhighgradeserousovariancarcinomaaretrospectiveanalysis
AT iwahashihideki comparisonofclinicalbehaviorbetweenmucinousovariancarcinomawithinfiltrativeandexpansileinvasionandhighgradeserousovariancarcinomaaretrospectiveanalysis
AT tsudahitoshi comparisonofclinicalbehaviorbetweenmucinousovariancarcinomawithinfiltrativeandexpansileinvasionandhighgradeserousovariancarcinomaaretrospectiveanalysis
AT takanomasashi comparisonofclinicalbehaviorbetweenmucinousovariancarcinomawithinfiltrativeandexpansileinvasionandhighgradeserousovariancarcinomaaretrospectiveanalysis